Transient Ischemic Attack Market Analysis | Focusing on Vital Players like Koninklijke Philips N.V., Stryker Corporation, Johnson & Johnson Services, Boston Scientific Corporation, etc

Market Research Future (MRFR)’s latest study reveals that the “Global Transient Ischemic Attack Market”, the report offer detailed Analysis about the Top Trends and Current Scenario with competitive landscape and key regions development status.

A transient ischemic attack (TIA) is like a stroke that is able to produce similar symptoms. Usually, these symptoms last only a few minutes and no permanent damage is caused. These strokes are often referred as ministroke, and a transient ischemic attack may be a warning. Favorable medical device regulation, the growing demand for diagnosis of chronic diseases, rising prevalence of lifestyle diseases, and increasing geriatric population are some of the key factors driving the transient ischemic attack market. However, the risk associated with surgical techniques and rising treatment cost and hospital stay may hinder the growth of the market to an extent. As per Market Research Future (MRFR)’s new report, the global transient ischemic attack market is expected to grow at a CAGR of 6.08% during the forecast period 2017–2023.

Request Sample copy at https://www.marketresearchfuture.com/sample_request/5025

Transient Ischemic Attack Market: Competitive Dashboard

Some of key the players in the transient ischemic attack market are Stryker Corporation (U.S.), Boston Scientific Corporation (Germany), Pfizer Inc. (U.S.), F. Hoffmann-La Roche AG (Switzerland), GE Healthcare (U.S.), Medtronic PLC (U.S.), Boehringer Ingelheim GmbH (Germany), EnteroMedics Inc. (U.S.), Boston Scientific Corporation (US), NeuroMetrix, Inc.(U.S.), Inspire Medical Systems, Inc.(U.S.), Electrical Geodesics Inc. (U.S.), Hologic (U.S.), Koninklijke Philips N.V. (Netherland), Johnson & Johnson Services Inc. (U.S.), Sanofi (France), Bayer AG (Germany), Siemens AG (Germany), Abbott Laboratories Inc. (U.S.), Penumbra, Inc. (U.S.), Merck & Co., Inc. (U.S.), LivaNova PLC (U.K), ElectroCore Medical LLC (U.S.), Cyberonics, Inc. (US), ImThera Medical (U.S.), and, Nihon Kohden Corporation (Japan), Masimo Corporation (U.S.), and Esaote (Italy).

Global Transient Ischemic Attack Market: Regional Segmentation

In this report, the global transient ischemic attack market has been segmented into five key regions namely, North America, South America, Europe, Asia Pacific (APAC), and the Middle East & Africa (MEA). North America and South America collectively dominate the transient ischemic attack market owing to the high healthcare expenditure, growing demand for diagnosis of chronic diseases, and well-developed technology. Apart from these two regions, Europe and APAC are the two other important markets for TIA. The MEA holds the least share of the global transient ischemic attack market owing to the presence of several poor and slow developing third-world countries in Africa.

Major TOC of Transient Ischemic Attack Market Research Report – Forecast to 2023:

1 Report Prologue

2 Executive Summary

3 Market Introduction

4 Research Methodology

5 Market Dynamics

6 Market Factor Analysis

7 Global Transient Ischemic Attack Market, by Diagnosis

8 Global Transient Ischemic Attack Market, by Treatment

9 Global Transient Ischemic Attack Market, by Age Groups

10 Global Transient Ischemic Attack Market, by End-User

11 Global Transient Ischemic Attack Market, by Region

12 Competitive Landscape

13 Company

14 Conclusion

15 Appendix

Browse Complete 226 Pages Premium Research Report Enabled with 337 Respective Tables and Figures at https://www.marketresearchfuture.com/reports/transient-ischemic-attack-market-5025

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

This release was published on openPR.